Q4 2024 Management View The CEO, David Garofalo, highlighted record revenues and positive operating cash flows for 2024, demonstrating portfolio growth. He announced guidance for 2025 of 5,700 to ...

WisdomTree's 2024 report highlights 21% revenue growth, $114B AuM, and undervaluation at 12x forward earnings. Read our ...

If you want to delve into the historical earnings , check out these free ... for high growth, you'll want to see a business's capital employed also increasing. To sum it up, Scully Royalty is ...

The company’s conservative management and strategic acquisitions, like the Caserones royalty, provide strong cash flow and long-term growth potential. EMX’s solid balance sheet and numerous ...

Narrow-moat Royalty Pharma’s fourth-quarter results largely tracked our expectations. Portfolio receipts for the quarter totaled $742 million, a 1% year-over-year increase. This growth was ...

(TOPZ) reported its Q4 2024 earnings, showcasing significant growth in royalty production and strategic ... marking an 87% free cash flow margin. Despite the absence of specific earnings per ...

The firm was honored specifically for its Technology Opportunities strategy, which focuses on ... and serving as exceptional growth equity partners for CEOs and investors. GrowthCap also assessed ...

(TOPZ) reported its Q4 2024 earnings, showcasing significant growth in royalty production and strategic acquisitions. The company's revenue for the quarter reached $82.9 million, with a robust cash ...